Cardiovascular variability reflects autonomic regulation of blood pressure (BP) and heart rate (HR). However, systolic BP (SBP) variability also may be induced by fluctuations in stroke volume through left ventricular end-diastolic pressure (LVEDP) variability via dynamic ventricular-arterial coupling during respiration. We hypothesized that dynamic ventriculararterial coupling is modulated by changes in left ventricular compliance associated with altered preload and that a cascade control mechanism of ventricular-arterial coupling with arterial-cardiac baroreflex function contributes to the genesis of cardiovascular variability at the respiratory frequency. Seven healthy young subjects underwent 6-min recordings of beat-by-beat LVEDP, SBP, and HR in the supine position with controlled respiration at 0.2 Hz during hyperand hypovolemia. Spectral and transfer function analysis of these variables was conducted between 0.18 and 0.22 Hz. Dynamic ventricular-arterial coupling gain (Gain LVEDP-SBP) was smaller by 25% (P ϭ 0.009) during hypervolemia than during hypovolemia, whereas arterial-cardiac baroreflex function gain (Gain SBP-HR) was similar. As predicted from a cascade model, a linear relationship between Gain LVEDP-HR and LVEDP-SBP times Gain SBP-HR was identified (R 2 ϭ 0.93, P Ͻ 0.001). Gain LVEDP-HR was smaller by 40% (P ϭ 0.04) during hypervolemia than during hypovolemia, leading to a reduction in spectral power of HR variability by 45% (P ϭ 0.08). We conclude that dynamic ventricular-arterial coupling gain is reduced during hypervolemia because of a decrease in left ventricular compliance. A cascade model of ventricular-arterial coupling with the arterial-cardiac baroreflex contributes to the genesis of cardiovascular variability at the respiratory frequency.
heart rate variability; blood pressure variability; cardiac mechanics QUANTIFICATION OF CARDIOVASCULAR variability has been established as a tool to examine autonomic function in patients with cardiovascular disease (40) . For example, patients with congestive heart failure (CHF) (4, 34, 39) or with myocardial infarction (24, 44) show significantly depressed heart rate (HR) variability associated with increases in mortality. These observations have been attributed to the presence of impaired autonomic function interacting with the presence of cardiovascular disease. However, because HR variability is only the output variable of complicated cardiovascular and respiratory control systems, both neural and nonneural control mechanisms may contribute to the changes in HR variability (12, 37, 46, 48) .
Short-term HR variability at respiratory frequencies is likely to be produced by the complicated interactions between the arterial-cardiac baroreflex (3, 31, 37) and central respiratory control mechanisms (13) . Although the specific mechanisms underlying short-term HR variability are still under debate (3, 13, 31, 37) , it is generally accepted that HR variability at the respiratory frequency is modulated by efferent vagal activity to the sinus node, because it is largely eliminated by atropine (12, 37) .
Conversely, recent studies demonstrated significant contributions of nonneural control mechanisms to blood pressure (BP) variability at the respiratory frequency because BP variability at the respiratory frequency did not change after complete autonomic blockade (37, 48) . In addition, several studies demonstrated the existence of stroke volume (SV) variability at the respiratory frequency (14, 16, 21, 42) , suggesting that SV variability may lead to BP variability via nonneural ventricular-arterial coupling. Specifically, we have speculated (2, 26) that changes in cardiac filling volume during respiration produce changes in left ventricular end-diastolic pressure (LVEDP) via the left ventricular pressure-volume relationship (Fig. 1) . Sequentially, changes in LVEDP (preload) produce changes in SV and hence systolic BP (SBP) (afterload) via the Starling mechanism ( Fig. 1) (2, 26) . Of note, both of these relationships also are affected by changes in intrathoracic pressure per se during respiration via ventricular interdependence and/or transmural pressure changes (16, 21) . Therefore, it is conceivable that the dynamic transmission properties between the LVEDP and SBP (dynamic ventricular-arterial coupling) are likely to be determined by the specific slopes of the cardiac mechanical curves as illustrated in Fig. 1 .
It is generally accepted that the baroreflex transfers SBP variability into changes in HR via the modulation of autonomic neural activity (47) . Because SBP variability at the respiratory frequency is produced primarily by the nonneural control of dynamic ventricular-arterial coupling (14, 16, 21, 37, 42, 48) , HR variability at the respiratory frequency would be produced at least partly by the cascade mechanism of dynamic ventricular-arterial coupling with the arterial-cardiac baroreflex (Fig. 1) .
The primary aim of the present study was to test the hypothesis that dynamic ventricular-arterial coupling is modulated by changes in left ventricular compliance associated with changes in left ventricular preload. Furthermore, we hypothesized that a cascade control mechanism of ventriculararterial coupling with arterial-cardiac baroreflex function contributes to the genesis of cardiovascular variability at the respiratory frequency.
For these aims, we used a two-component cascade model to determine both the individual and the combined effects of dynamic ventricular-arterial coupling and the arterial-cardiac baroreflex for the genesis of SBP and HR variability under hypo-and hypervolemic conditions. Hypovolemia was induced after administration of a diuretic agent (furosemide), and hypervolemia was induced with normal saline infusion. The purpose of these interventions was to alter the operating points of dynamic ventricular-arterial coupling located on the cardiac mechanical curves as indicated in Fig. 1 in order to test the specific hypothesis of this study.
METHODS

Subjects
Seven sedentary nonsmoking healthy men (ages 20 -35 yr) with a body mass index of 25 Ϯ 0.6 kg/m 2 participated in this study. All subjects were screened with a detailed medical history, a physical examination, and a baseline 12-lead ECG. The study was performed in accordance with the Declaration of Helsinki. The experimental procedures were explained to all subjects, with informed consent obtained as approved by the Institutional Review Boards of the University of Texas Southwestern Medical Center at Dallas and Presbyterian Hospital of Dallas.
Measurements
For each subject, the R-R interval was continuously monitored with a three-lead ECG (Hewlett-Packard). Photoplethysmography (Finapres, Ohmeda) was used to continuously measure finger arterial BP (ABP) with the transducer positioned at heart level. For measurements of pulmonary capillary wedge pressure (PCWP) and pulmonary arterial pressure (PAP), a 6-F balloon-tipped, fluid-filled catheter (Swan-Ganz, Baxter) was placed through an antecubital vein into the pulmonary artery under fluoroscopic guidance. All intracardiac pressures were referenced to atmospheric pressure, with the pressure transducer (Transpac IV, Abbott) zero-reading set at 5 cm below the sternal angle. Mean PCWP was determined visually at end expiration. Beat-by-beat pulmonary artery diastolic pressure (PAD) was used as an index of beat-by-beat LVEDP to avoid prolonged balloon inflation for safety reasons (15) . Cardiac output was measured with a modified acetylene rebreathing technique using acetylene as the soluble and helium as the insoluble gas (27, 43) . Then cardiac output and HR during the rebreathing were used to calculate the SV. Baseline plasma volume (PV) was measured by Evans blue dye, and then changes in PV were estimated during hypervolemia and hypovolemia from hematocrit changes according to the method of Van Beaumont (45) .
Experimental Protocol
All experiments were performed in the morning at least 2 h after a light breakfast in a quiet environmentally controlled laboratory with an ambient temperature of 25°C. The subjects were asked to refrain from heavy exercise and caffeinated or alcoholic beverages for at least 24 h before the tests. To assess the effect of central volume changes, two specific conditions of hypervolemia and hypovolemia were utilized. Subjects rested for at least 30 min in the supine position to stabilize their hemodynamics. Hypervolemia was then induced with warm (37°C) isotonic saline infusion of 30 ml/kg at a rate of 100 -150 ml/min with an 18-gauge intravenous catheter and an infusion bag pressurized to 250 mmHg. Our previous studies (2, 26) showed that this amount and rate of saline infusion lead clearly to higher left ventricular end-diastolic volume, SV, and PCWP. PAP was monitored continuously, and PCWP was measured intermittently during saline infusion for safety reasons. Immediately after saline infusion, SV and PCWP were measured, and then subjects were asked to breathe at a The input signal of G1 is LVEDP, and the output signal is systolic blood pressure (SBP). Hypo and Hyper, expected operating point during hypovolemia and hypervolemia, respectively. G2 represents arterial-cardiac baroreflex function. The input signal of G2 is SBP, and the output signal is heart rate (HR; R-R interval). G0 represents total transfer function consisting of series of G1 and G2. SV, stroke volume; AP, arterial pressure. controlled 12 min Ϫ1 frequency for 6 min by following a moving cursor on a breathing pattern displayed on a computer. The breathing pattern used was an equal amplitude and an equal time interval of sawtooth waveforms. All subjects followed the breathing protocol very well without complaint of any discomfort. We selected controlled-frequency breathing to avoid changes in HR variability induced by changes in respiratory patterns during spontaneous breathing (6, 18) and to avoid changes in BP variability at the respiratory frequencies being contaminated by those fluctuations at the lower frequencies (Ͻ0.15 Hz) (30) . Six-minute data segments of PAP, ABP, and ECG were recorded for spectral and transfer function analysis. Hypovolemia was induced on a separate occasion with intravenous administration of 20 mg of furosemide (Lasix). After administration of furosemide, the change in PCWP was monitored continuously over 2 h to confirm an ϳ25% reduction of PCWP (33) . The same measurements for spectral and transfer function analysis as during hypervolemia were performed under hypovolemic conditions. These two experiments were separated by at least 3 days but no more than 3 wk. In addition, a 6-min random-frequency breathing protocol with an averaged frequency of 15 Ϯ 11 min Ϫ1 was performed before the controlled-breathing protocol during both hypervolemia and hypovolemia to confirm our assumption that beat-by-beat changes in LVEDP are induced mainly by respiration and that changes in SBP and HR variability during changes in central volume have little if any effect on the changes in LVEDP.
Data Analysis
Spectral and transfer function estimation. PAP, ABP, and ECG waveforms were sampled at 1 kHz and digitized at 12 bits with an analog-to-digital converter (Das-20, Metrabyte). Digitized signals were stored in a laboratory computer and processed with a customdesigned program for PAD, SBP, and R-wave detection. Beat-to-beat LVEDP (estimated from PAD), SBP, and HR (calculated from R-R interval) were linearly interpolated and then resampled at 2 Hz for spectral analysis. The time series of LVEDP, SBP, and HR were first detrended with third-order polynomial fitting and then subdivided into 256-point segments with 50% overlap for spectral estimation. This process resulted in five segments of data over the 6-min period recordings. Fast Fourier transforms were implemented with each Hanning-windowed data segment and then averaged to calculate autospectra [S X ⅐ X(f)] and cross-spectra [SX ⅐ Y(f)] for LVEDP, SBP, and HR variability, respectively. The spectral resolution for these estimates is 0.0078 Hz.
To quantify the dynamic relationship between SBP and HR variability, transfer function analysis between these variables was used (20, 25, 31, 37) . Similarly, transfer function between changes in preload (LVEDP) and afterload (SBP) of the left ventricle was estimated to quantify dynamic ventricular-arterial coupling (49) . 
where S LVEDP ⅐ SBP(f), SSBP ⅐ HR(f), and SLVEDP ⅐ HR(f) are cross-spectra between LVEDP and SBP, SBP and HR, and LVEDP and HR, respectively, and SLVEDP ⅐ LVEDP(f) and SSBP ⅐ SBP(f) are the autospectra of LVEDP and SBP, respectively. Transfer function gain and phase were derived from the real part [HR(f)] and the imaginary part [HI(f)] of the complex transfer function as
Gain and phase reflect the relative amplitude and time relationships between the input and output signals of the system modeled by H(f) over a specified frequency range. Coherence function was derived from S X ⅐ X(f), SY⅐Y(f), and SX⅐Y(f) as
The reliability of linear transfer function estimation was evaluated by the estimates of coherence function in this study. Because coherence function between LVEDP and SBP variability was low (Ͻ0.5) at the frequency range below 0.15 Hz even when random breathing was applied (see Figs. 2 and 4) , we used data at the high-frequency range between 0.18 and 0.22 Hz during controlledfrequency breathing (0.2 Hz) to estimate transfer functions between LVEDP, SBP, and HR variability, where coherence function was high (Ͼ0.5) under all experimental conditions. The spectral power of LVEDP, SBP, and HR also was calculated in the high-frequency range (0.18 -0.22 Hz) by integrating the corresponding autospectra (20, 37, 48) . Mean values of gain, phase, and coherence were calculated in the high-frequency range and averaged for all subjects under hypo-and hypervolemic conditions (20, 37, 48) .
Finally, to validate the proposed two-component cascade model, the relationship between the product of Gain LVEDP-SBP and Gain SBP-HR and the estimation of Gain LVEDP-HR was assessed by using linear regression of all the data obtained under hypo-and hypervolemic conditions (23, 38) .
Statistics. Variables were compared between hypovolemia and hypervolemia by paired t-test. A P value of Ͻ0.05 was considered statistically significant. Data are presented as means Ϯ SE.
RESULTS
Steady-State Hemodynamics
PCWP, PAD, SV, and PV all were significantly higher during hypervolemia than during hypovolemia (Table 1) , consistent with the expected increases in central volume. HR and SBP were significantly higher during hypervolemia than during hypovolemia (Table 1) . Total HR and SBP variability quanti- Values are means Ϯ SE. Hypovolemia, after intravenous furosemide injection; hypervolemia, after acute saline infusion; SD, standard deviation of time series; PV, plasma volume; PCWP, pulmonary capillary wedge pressure; PAD, pulmonary artery diastolic pressure; SV, stroke volume; SBP and DBP, systolic and diastolic blood pressure, respectively; HR, heart rate; HF, spectral power in high-frequency ranges (0.18 -0.22 Hz); bpm, beats per minute. *P Ͻ 0.05; †P ϭ 0.08.
fied by standard deviation of the time series were significantly lower during hypervolemia (Table 1) .
Spectral and Transfer Function Analysis
Representative data of time series and autospectra in LVEDP, SBP, and HR during controlled breathing from one subject are shown in Fig. 2 . Averaged data of autospectra in LVEDP, SBP, and HR in hyper-and hypovolemia during controlled breathing are also shown in Fig. 2 . Averaged data of transfer function and coherence function in hyper-and hypovolemia during controlled breathing are shown in Fig.  3 . Averaged data of autospectra in LVEDP, SBP, and HR and coherence function during random breathing are shown in Fig. 4 .
High-frequency power of LVEDP was significantly higher during hypervolemia than during hypovolemia (Table 1 ; Fig.  5 ) (P Ͻ 0.05). High-frequency power of HR variability tended to decrease during hypervolemia but did not reach statistical significance (Table 1 ) (P ϭ 0.08). High-frequency power of SBP variability was not changed (Table 1) .
Peak values of coherence (Ͼ0.8) were observed around the respiratory frequency for all transfer functions (LVEDP-HR, LVEDP-SBP, and SBP-HR) (Fig. 3) . The mean values of coherence function were Ͼ0.5 for all transfer functions in the high-frequency range, indicating the reliability of transfer function gain and phase estimates in the high-frequency range.
Gain LVEDP-SBP was significantly lower during hypervolemia than during hypovolemia (Figs. 3 and 5; see Fig. 7 ) (hypovolemia 1.31 Ϯ 0.09 and hypervolemia 0.97 Ϯ 0.12 mmHg/mmHg; P ϭ 0.009). However, no change in Gain SBP-HR was observed between hypovolemia and hypervolemia ( Fig. 3; see Fig. 7 ) (hypovolemia 1.31 Ϯ 0.19 and hypervolemia 1.18 Ϯ 0.22 beats ⅐ min Ϫ1 ⅐ mmHg Ϫ1 ; P ϭ 0.19). Gain LVEDP-HR was significantly lower during hypervolemia than during hypovolemia ( Fig. 3; see Fig. 7 ) (hypovolemia 2.09 Ϯ 0.56 and hypervolemia 1.25 Ϯ 0.28 beats ⅐ min Ϫ1 ⅐ mmHg Ϫ1 ; P ϭ 0.04). As expected, a strong linear relationship (R 2 ϭ 0.93, P Ͻ 0.001) was observed between the product of Gain LVEDP-SBP and Gain SBP-HR and the estimate of Gain LVEDP-HR (Fig. 6) .
Phase of LVEDP-SBP was significantly lower in hypervolemia than in hypovolemia ( LVEDP-SBP was negative in the high-frequency ranges in 11 of 14 data sets (7 subjects tested during hyper-and hypovolemia). Phases of SBP-HR and LVEDP-HR were positive in all data and were not different between hypervolemia and hypovolemia (Fig. 3) .
DISCUSSION
We obtained three major results that provide new evidence for the presence of nonneural control mechanisms for the genesis of cardiovascular variability in humans. First, we found that dynamic ventricular-arterial coupling gain (Gain LVEDP-SBP) was reduced significantly during hypervolemia compared with hypovolemia. These data suggest that a reduction in dynamic left ventricular compliance due to hypervolemia results in smaller changes in SV per unit changes in LVEDP, and hence smaller changes in SBP under dynamic conditions (Fig.  5) . Second, the presence of a strong linear relationship between the product of Gain LVEDP-SBP and Gain SBP-HR and the estimation of Gain LVEDP-HR demonstrates the validity of using a cascade model of cardiac mechanics with arterialcardiac baroreflex function to identify the nonneural control mechanisms of cardiovascular variability in humans (23, 38) (Figs. 6 and 7) . Finally, these findings suggest that left ventricular diastolic function may affect HR variability at the respiratory frequency via dynamic ventricular-arterial coupling rather than exclusively via an autonomic mechanism (Figs. 1  and 7 ).
Steady-State Hemodynamics
As expected by protocol and confirmed from PV changes, both PCWP and SV increased during hypervolemia, suggesting an upward shift of the operating point on both the left ventricular pressure-volume and Starling curves (Fig. 1) . The increase in steady-state SBP during hypervolemia was likely caused by an increase in SV and cardiac output. HR was higher in hypervolemia than in hypovolemia, consistent with the presence of a Bainbridge reflex during hypervolemia (17, 32) .
Dynamic Ventricular-Arterial Coupling
We assessed the transmission properties of preload (LVEDP) to afterload (SBP) of the left ventricle by using the cross-spectral method. In previous studies (2, 26), we have shown that the operational slope on the Starling curve, which determines the dynamic transmission properties between the beat-by-beat change in LVEDP and SV, decreased during hypervolemia. Consistent with these observations, a significant decrease in dynamic ventricular-arterial coupling gain (Gain LVEDP-SBP) was observed during hypervolemia in the present study (Fig. 5) .
As we expected, a prominent power of LVEDP variability and the highest coherence function between LVEDP and SBP were observed at the controlled respiratory frequency of 0.2 Hz (Figs.  2 and 3) . Moreover, LVEDP power at frequencies lower than 0.15 Hz was much larger during random-than fixed-frequency breathing (Figs. 2 and 4) . These findings support our assumption that LVEDP changes are caused primarily by respiration and that LVEDP changes produce SV and thus SBP variability via the pressure-volume and Starling mechanisms. Our results showed that the phase relationship of LVEDP-SBP was negative for most subjects under either hypo-or hypervolemic conditions, suggesting that changes in LVEDP precede SBP. These findings also are consistent with our assumption that changes in LVEDP produce changes in SBP via ventricular-arterial coupling. Furthermore, it is also possible that a dilated right ventricular chamber during hypervolemia alters the operational slopes of the pressure-volume and Starling curves via ventricular interdependence (16, 21) . In addition, changes in intrathoracic pressure during respiration per se also may alter the operational slopes of cardiac mechanical curves by changing transmural pressure (16, 21) . However, regardless of the specific underlying mechanisms, the results of the present study support the hypothesis that dynamic ventriculararterial coupling is dependent on cardiac preload due to changes in operational slopes on the cardiac mechanical curves that lead to the changes in SBP variability at respiratory frequencies.
High-frequency power of LVEDP increased in hypervolemia compared with hypovolemia. These changes may be explained by the pressure-volume relationship of the left ventricle. For example, if changes in cardiac filling volume due to respiration were equal between hypervolemia and hypovolemia, the pressure changes would be larger during hypervolemia than during hypovolemia because of the upward shifting of the operating point to a less compliant portion on the pressure-volume curve (Fig. 5) . This finding implies that the input variable of dynamic ventricular-arterial coupling, i.e., LVEDP variability, is also affected by left ventricular preload conditions.
Reliability of Cascade Model
LVEDP spectral power at a frequency range of Ͻ0.15 Hz in fixed-frequency breathing was much less than that during random-frequency breathing, while similar SBP and HR spec- Gain SBP-HR suggests the feasibility of using the proposed cascade model to represent both nonneural and neural control of cardiovascular variability at respiratory frequencies in humans (23, 38) .
In the high-frequency range, mean values of coherence function were Ͼ0.5 for all transfer function estimates. These data support the statistical reliability of transfer function gain estimation in this study.
High-frequency power of HR variability tended to decrease during hypervolemia. We attribute these changes at least partially to the reductions in the transfer function gain of LVEDP-SBP as suggested by the cascade model (Figs. 1 and 7) . In addition, HR variability also could be influenced directly by changes in respiration (6, 18) . Because carefully frequencycontrolled breathing was used to avoid the effect of changes in respiratory patterns on HR variability, the direct effects of respiration on changes in HR variability are likely to be small between the experimental conditions in the present study (6, 18) . We also cannot exclude mechanisms other than the cascade model to explain the reduction in HR variability at respiratory frequency during hypervolemia. For example, changes in LVEDP may affect autonomic nervous system activity and hence HR variability via cardiopulmonary receptors (13) . Furthermore, at least theoretically the Bainbridge reflex could directly contribute to changes in Gain LVEDP-HR and hence HR variability, although the exact mechanism and neural pathways underlying this reflex in humans are uncertain (32) .
Clinical Implications
It is possible that the effects of diastolic dysfunction on dynamic ventricular-arterial coupling and hence HR variability are more prominent in patients with CHF and/or coronary artery disease rather than that caused by an experimentally increased preload condition in healthy young volunteers. Several studies support this assumption. For example, studies in CHF patients showed either a linear (1) or a logarithmic (7) relationship between the ejection fraction of the left ventricle and the high-frequency power of HR variability. Also, a positive relationship between high-frequency power of HR variability and ejection fraction or mean acceleration of aortic flow was present in patients with coronary artery disease (5). Moreover, patients with restrictive cardiac diastolic filling showed a greater reduction in HR variability (35) .
The fact that continuous positive airway pressure (CPAP) improves prognosis in CHF patients has been explained by a reduction of sympathetic activity (19, 22) , and hence ventricular arrhythmias (36) , associated with a reduction of cardiac work caused by changes in ventricular interdependence and/or reduction in transmural pressure due to intrathoracic positive pressure (29, 41) . Our present findings suggest that CPAP also may improve dynamic ventricular-arterial coupling by changing the operational slopes on the pressure-volume and Starling curves via ventricular interdependence and/or changes in transmural pressure in CHF patients (29, 41) . Therefore, it is possible that improvement in dynamic ventricular-arterial coupling per se is related to the treatment effects of CPAP on CHF patients.
Study Limitations
There remains the possibility that HR changes affect SBP variability and hence Gain LVEDP-SBP through cardiac output changes, because cardiac output is the product of HR and SV. It has been reported, however, that systolic BP variability at the respiratory frequency is mainly determined by changes in SV, which produces pulse pressure via arterial compliance, whereas mean BP variability is more closely related with cardiac output changes (9, 14, 28, 42) . Theoretically, the transfer function gain between LVEDP and SBP variability could be decomposed into two components, i.e., a gain between LVEDP and SV variability via the Starling mechanism and a gain between SV and SBP variability via end-systolic ventricular-arterial coupling, reflecting arterial compliance (10) . Therefore, our findings of changes in Gain LVEDP-SBP could reflect either ventricular or arterial compliance, although it is unlikely that arterial compliance would change significantly during the present study protocol. To evaluate dynamic ventricular-arterial coupling in more detail, future studies will be required to estimate beat-to-beat SV variability, which will enable us to assess Gain LVEDP-SV and Gain SV-SBP separately.
Arterial-cardiac baroreflex function also may be affected by physiological changes other than volume status after saline infusion. For example, sodium-sensitive arterial baroreflex sensors may change arterial-cardiac baroreflex function because of chronic sodium loading during large changes in sodium intake (11) . Furthermore, changes in plasma osmolality may also affect baroreflex function after hypertonic saline infusion (8) . In addition, HR variability may be affected by physiological mechanisms such as respiratory gating (13) or the Bainbridge reflex (32) in concert with the arterial-cardiac baroreflex. Therefore, it is possible that arterial-cardiac baroreflex gain was similar between hypervolemia and hypovolemia in the present study because of the offsetting contributions of many physiological effects. However, whether acute changes in plasma sodium concentration affect the arterial baroreflex is uncertain; moreover, the changes in plasma osmolality and sodium concentration are likely to be small after "isotonic" saline infusion. Therefore, we speculate that the impact of these factors is likely to be small.
In conclusion, our results show that dynamic ventriculararterial coupling gain (Gain LVEDP-SBP) was reduced significantly during hypervolemia compared with hypovolemia, probably because of a reduction in dynamic left ventricular compliance during hypervolemia. These changes may lead to a reduction in HR variability via a cascade model of dynamic ventricular-arterial coupling with arterial-cardiac baroreflex function. These findings suggest that a reduction of HR variability in patients with CHF may be at least partially explained by nonneural mechanisms of left ventricular diastolic dysfunction.
